Side effects: Most patients have no significant side effects
The other historical doses (1 mg, 4 mg, 8 mg) remain Phase 2 / research reference points only
[DOI] [PMC free article] [PubMed] [Google Scholar] 142.Beckman J.S., Koppenol W.H
That puts them squarely in the third category, meaning their legal use in compounding hinges almost entirely on whether they make it onto the 503A Bulks List
The STEP trial program alone included multiple large-scale, randomized, double-blind, placebo-controlled trials with thousands of participants
Comparison table: fat loss peptide combinations Cost considerations and practical budgeting Running this combination involves ongoing costs that researchers should budget for before committing to a multi-month protocol